Abstract
The HLA-identical sibling donors of 111 bone marrow transplantation (BMT) recipients were randomised to receive or not to receive tetanus–diphtheria (T–d), Haemophilus influenzae type b (Hib), and inactivated poliovirus (IPV) vaccines 2–10 weeks before BM harvest. Fifty-three (DV+ group) recipients received the graft from a vaccinated donor and 58 (DV− group) from an unvaccinated donor. All recipients were vaccinated with the T–d, Hib and IPV vaccines at 3, 6 and 12 months after BMT. Diphtheria and Hib antibody concentrations were consistently higher in the DV+ than in the DV− group from 6 months post transplantation onwards. The differences were significant at 6 and 13 months for diphtheria and at 12 months for Hib antibody concentrations. Tetanus, PV1, PV2 and PV3 antibody levels were similar in both groups. Patients transplanted from donors with high tetanus, diphtheria and Hib antibody concentrations had higher respective antibody concentrations after BMT than those transplanted from donors with low antibody concentrations. Especially patients whose donors have low-specific antibody concentrations may benefit from donor vaccination with protein and conjugate vaccines.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Atkinson K . Reconstruction of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transplant 1990; 5: 209–226.
Ljungman P, Wiklund-Hammarsten M, Duraj V, Hammarström L, Lönnqvist B, Paulin T et al. Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. J Infect Dis 1990; 162: 496–500.
Engelhard D, Handsher R, Naparstek E, Hardan I, Strauss N, Aker M et al. Immune response to polio vaccination in bone marrow transplant recipients. Bone Marrow Transplant 1991; 8: 295–300.
Ljungman P, Duraj V, Magnius L . Response to immunization against polio after allogeneic marrow transplantation. Bone Marrow Transplant 1991; 7: 89–93.
Barra A, Cordonnier C, Preziosi M-P, Intrator L, Hessel L, Fritzell B et al. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. J Infect Dis 1992; 166: 1021–1028.
Li Volti S, Mauro L, Di Gregorio F, Romeo MA, Lupo L, Pizzarelli G et al. Immune status and immune response to diphtheria-tetanus and polio vaccines in allogeneic bone marrow-transplanted thalassemic patients. Bone Marrow Transplant 1994; 14: 225–227.
Parkkali T, Ruutu T, Stenvik M, Kuronen T, Käyhty H, Hovi T et al. Loss of protective immunity to polio, diphtheria and Haemophilus influenzae type b after allogeneic bone marrow transplantation. APMIS 1996; 104: 383–388.
Parkkali T, Käyhty H, Ruutu T, Volin L, Eskola J, Ruutu P . A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT. Bone Marrow Transplant 1996; 18: 961–967.
Parkkali T, Ölander R-M, Ruutu T, Vuontela K, Volin L, Eskola J et al. A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT. Bone Marrow Transplant 1997; 19: 933–938.
Parkkali T, Stenvik M, Ruutu T, Hovi T, Volin L, Ruutu P . Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT. Bone Marrow Transplant 1997; 20: 663–668.
Vance E, George S, Guinan EC, Wheeler C, Antin JH, Ambrosino DM et al. Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation. Bone Marrow Transplant 1998; 22: 735–741.
Storek J, Ferrara S, Ku N, Giorgi JV, Champlin RE, Saxon A . B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny? Bone Marrow Transplant 1993; 12: 387–398.
Wimperis JZ, Brenner MK, Prentice HG, Thompson EJ, Hoffbrand AV . B cell development and regulation after T cell-depleted marrow transplantation. J Immunol 1987; 138: 2445–2450.
Molrine DC, Guinan EC, Antin JH, Parsons SK, Weinstein HJ, Wheeler C et al. Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation. Blood 1996; 87: 3012–3018.
Molrine DC, Antin JH, Guinan EC, Soiffer RJ, MacDonald K, Malley R et al. Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation. Blood 2003; 101: 831–836.
Atkinson K, Storb R, Prentice RL, Weiden PL, Witherspoon RP, Sullivan K et al. Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood 1979; 53: 720–731.
Cordonnier C, Bernaudin J-F, Bierling P, Huet Y, Vernant J-P . Pulmonary complications occurring after allogeneic bone marrow transplantation. A study of 130 consecutive transplanted patients. Cancer 1985; 58: 1047–1054.
Aucouturier P, Barra A, Intrator L, Cordonnier C, Schulz D, Duarte F et al. Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. Blood 1987; 70: 779–785.
Wingard JR . Advances in the management of infectious complications after bone marrow transplantation. Bone Marrow transplant 1990; 6: 371–383.
Lossos IS, Breuer R, Or R, Strauss N, Elishoov H, Naparstek E et al. Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study. Transplantation 1995; 60: 672–678.
Peltola H . Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: Global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000; 13: 302–317.
Heath PT, McVernon J . The UK Hib vaccine experience. Arch Dis Child 2002; 86: 396–399.
Garner D, Weston V . Effectiveness of vaccination for Haemophilus influenzae type b. Lancet 2003; 361: 395–396 (research letter).
Ruutu T, Volin L, Parkkali T, Juvonen E, Elonen E . Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study. Blood 2000; 96: 2391–2398.
Thomas ED, Storb R, Clift RA, Feder A, Johnson FL, Neiman PE et al. Bone marrow transplantation (second of two parts). New Engl J Med 1975; 292: 895–902.
Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204–217.
Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267–276.
Rapola S . The Finnish vaccination schedule was reformed at the beginning of the year 2005 (In Finnish). Tabu 2005; 1: 4–6.
Kristiansen M, Aggerbeck H, Heron I . Improved ELISA for determination of anti- diphtheria and/or anti-tetanus antitoxin antibodies in sera. APMIS 1997; 105: 843–853.
Mäkelä PH, Käyhty H, Leino T, Auranen K, Peltola H, Ekström N et al. Long-term persistence of immunity after immunisation with Haemophilus influenzae type b conjugate vaccine. Vaccine 2003; 22: 287–292.
Käyhty H, Peltola H, Karanko V, Mäkelä PH . The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983; 147: 1100.
Fernandez J, Levine OS, Sanchez J, Balter S, LaClaire L, Feris J et al. Prevention of Haemophilus influenzae type b colonization by vaccination: Correlation with serum anti-capsular IgG concentration. J Infect Dis 2000; 182: 1553–1556.
Albrecht P, van Steenis G, van Wezel AL, Salk J . Standardization of poliovirus neutralizing antibody tests. Rev Infect Dis 1984; 6 (S2): S540–S544.
Storek J, Dawson MA, Lim LC-L, Burman BE, Stevens-Ayers T, Viganego F et al. Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation. Bone Marrow Transplant 2004; 33: 337–346.
Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. New Engl J Med 1995; 332: 143–149.
Weinberg K, Annett G, Kashyap A, Lenarsky C, Forman SJ, Parkman R . The effect of thymic function on immunocompetence following bone marrow transplantation. Biol Blood Marrow Transplant 1995; 1: 18–23.
Ottinger HD, Beelen DW, Scheulen B, Schaefer UW, Grosse-Wilde H . Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 1996; 88: 2775–2779.
Charbonnier A, Sainty D, Faucher C, Arnoulet C, Chabannon C, Blaise D . Immune reconstitution after blood cell transplantation. Hematol Cell Ther 1997; 39: 261–264.
Pavletic ZS, Joshi SS, Pirruccello SJ, Tarantolo SR, Kollath J, Reed EC et al. Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies. Bone Marrow Transplant 1998; 21: 33–41.
Storek J, Dawson MA, Storer B, Stevens-Ayers T, Maloney DG, Marr KA et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001; 97: 3380–3389.
Saxon A, Mitsuyasu R, Stevens R, Champlin RE, Kimata H, Gale RP . Designed transfer of specific immune responses with bone marrow transplantation. J Clin Invest 1986; 78: 959–967.
Guinan EC, Molrine DC, Antin JH, Lee MC, Weinstein HJ, Sallan SE et al. Polysaccharide conjugate vaccine responses in bone marrow transplant patients. Transplantation 1994; 57: 677–684.
Engelhard D, Cordonnier C, Shaw PJ, Parkkali T, Guenther C, Martino R et al. Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey. Br J Haematol 2002; 117: 444–450.
Ljungman P, Aschan J, Gustafsson B, Lewensohn-Fuchs I, Winiarski J, Ringdén O . Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients. Bone Marrow Transplant 2004; 34: 1067–1069.
Acknowledgements
We thank Ritva Keskimäki and Sari Haavisto for vaccinating the donors and patients and for organising the collection of serum samples.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Parkkali, T., Käyhty, H., Hovi, T. et al. A randomized study on donor immunization with tetanus–diphtheria, Haemophilus influenzae type b and inactivated poliovirus vaccines to improve the recipient responses to the same vaccines after allogeneic bone marrow transplantation. Bone Marrow Transplant 39, 179–188 (2007). https://doi.org/10.1038/sj.bmt.1705562
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705562
Keywords
This article is cited by
-
Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016
Annals of Hematology (2016)
-
Pretransplant vaccinations in allogeneic stem cell transplantation donors and recipients: an often-missed opportunity for immunoprotection?
Bone Marrow Transplantation (2015)
-
Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients
Bone Marrow Transplantation (2013)
-
Significant loss of hepatitis A Ab after allogeneic hematopoietic SCT in pediatric patients
Bone Marrow Transplantation (2010)
-
Impfungen bei onkologischen Patienten
best practice onkologie (2008)